US FDA staff raises concerns over OTC use of Perrigo's birth control pill

The U.S. health regulator's reviewers on Friday raised concerns around allowing Perrigo Co's birth control drug over the counter, saying switching to non-prescription sale could lead to inappropriate usage by consumers.

Related Keywords

United States ,Bengaluru ,Karnataka ,India ,Leroy Leo ,Shounak Dasgupta ,Us Supreme Court ,Perrigo Co ,Thomson Reuters Trust Principles ,Drug Administration ,Reuters ,Thomson Reuters Trust ,Nrlpa Ohlt ,Rsbi Regulatory Oversight ,Rhpi Regulatory ,Cmpny ,Gen ,Heca ,Medreg ,Phag08 ,Phar ,Phar08 ,Phar1 ,Phmr ,Publ ,Regs ,Weu ,Europ ,Mie ,Ezc ,Rhpi Government Health Policy ,Rhpi Public Health ,Birthc ,Genhlt ,Hcpol ,Hea ,Hsehld ,Ncyc ,Privt ,Psnpr ,Pubhea ,Gamers ,Us ,Namer ,Topnws ,Mtpix ,Pxp ,Legal ,Reuters Legal ,